| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 682996 | Null | 0.0212053315848711 | -0.040364936 |
| NSC 709358 | 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol | 0.0212053315848711 | -0.28724 |
| NSC 711077 | Null | 0.0212053315848711 | 0.064837631 |
| NSC 716503 | Null | 0.0212053315848711 | -0.0078689744 |
| NSC 731704 | 1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. | 0.0212053315848711 | 0.13510524 |
| NSC 743433 | 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one | 0.0212053315848711 | 0.063241019 |
| NSC 755442 | Null | 0.0212053315848711 | 0.045136643 |
| NSC 762901 | trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide | 0.0212053315848711 | 0.036834587 |
| NSC 683557 | Camptothecin Derivative | 0.0220292715546631 | -0.13825942 |
| NSC 697685 | Null | 0.0220292715546631 | 0.0036136499 |